ArticleNano reviews2011
Engineering periplasmic ligand binding proteins as glucose nanosensors.
Article in Nano reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Retracing the evolution of a modern periplasmic binding protein.Protein science : a publication of the Protein Society · 2023Article
- Nanotheranostics: application of nanosensors in diabetes management.Journal of diabetes and metabolic disorders · 2023Review
- Theranostic Advances of Bionanomaterials against Gestational Diabetes Mellitus: A Preliminary Review.Journal of functional biomaterials · 2021Review
- Electrochemiluminescence sensor based on cyclic peptides-recognition and Au nanoparticles assisted graphitic carbon nitride for glucose determination.Mikrochimica acta · 2021Article
- The 40-Year Mystery of Insect Odorant-Binding Proteins.Biomolecules · 2021Review
- A FRET-based biosensor for the quantification of glucose in culture supernatants of mL scale microbial cultivations.Microbial cell factories · 2019Article
- Open Conformation of theBiology · 2018Article
- Fluorescent Nanobiosensors for Sensing Glucose.Sensors (Basel, Switzerland) · 2018Review
- Redesign of LAOBP to bind novel l-amino acid ligands.Protein science : a publication of the Protein Society · 2018Article
- Dynamical persistence of active sites identified in maltose-binding protein.Journal of molecular modeling · 2017Article
- Ligand binding specificity of the Escherichia coli periplasmic histidine binding protein, HisJ.Protein science : a publication of the Protein Society · 2017Article
- Recent advances in application of biosensors in tissue engineering.BioMed research international · 2014Review
- Microbial biosensors: engineered microorganisms as the sensing machinery.Sensors (Basel, Switzerland) · 2013Review
- myo-inositol and D-ribose ligand discrimination in an ABC periplasmic binding protein.Journal of bacteriology · 2013Article
- Fluorescence intensity- and lifetime-based glucose sensing using glucose/galactose-binding protein.Journal of diabetes science and technology · 2013Review
- Clinical metabolomics: the next stage of clinical biochemistry.Blood transfusion = Trasfusione del sangue · 2012Review
- Induced fit or conformational selection? The role of the semi-closed state in the maltose binding protein.Biochemistry · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes affects over 100 million people worldwide. Better methods for monitoring blood glucose levels are needed for improving disease management. Several labs have previously made glucose nanosensors by modifying members of the periplasmic ligand binding protein superfamily. This minireview summarizes recent developments in constructing new versions of these proteins that are responsive within the physiological range of blood glucose levels, employ new reporter groups, and/or are more robust. These experiments are important steps in the development of novel proteins that have the characteristics needed for an implantable glucose nanosensor for diabetes management: specificity for glucose, rapid response, sensitivity within the physiological range of glucose concentrations, reproducibility, and robustness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.